Eli Lilly Sues Telehealth Startups Over GLP-1 Knockoffs, Escalating Legal Battle
As the pharmaceutical giant targets compounded GLP-1 drugs, franchises offering medical weight loss like Lindora may face rising costs and tighter access to popular treatments.